These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

425 related items for PubMed ID: 29517367

  • 41. Effect of 2013 ACC/AHA Blood Cholesterol Guidelines on Statin Treatment Patterns and Low-Density Lipoprotein Cholesterol in Atherosclerotic Cardiovascular Disease Patients.
    Okerson T, Patel J, DiMario S, Burton T, Seare J, Harrison DJ.
    J Am Heart Assoc; 2017 Mar 17; 6(3):. PubMed ID: 28314797
    [Abstract] [Full Text] [Related]

  • 42. Potential Cardiovascular Disease Events Prevented with Adoption of the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline.
    Bress AP, Colantonio LD, Cooper RS, Kramer H, Booth JN, Odden MC, Bibbins-Domingo K, Shimbo D, Whelton PK, Levitan EB, Howard G, Bellows BK, Kleindorfer D, Safford MM, Muntner P, Moran AE.
    Circulation; 2019 Jan 02; 139(1):24-36. PubMed ID: 30586736
    [Abstract] [Full Text] [Related]

  • 43. Adoption of the 2013 American College of Cardiology/American Heart Association Cholesterol Management Guideline in Cardiology Practices Nationwide.
    Pokharel Y, Tang F, Jones PG, Nambi V, Bittner VA, Hira RS, Nasir K, Chan PS, Maddox TM, Oetgen WJ, Heidenreich PA, Borden WB, Spertus JA, Petersen LA, Ballantyne CM, Virani SS.
    JAMA Cardiol; 2017 Apr 01; 2(4):361-369. PubMed ID: 28249067
    [Abstract] [Full Text] [Related]

  • 44. Cardiovascular Risk and Statin Eligibility in Primary Prevention: A Comparison between the Brazilian and the AHA/ACC Guidelines.
    Cesena FHY, Valente VA, Santos RD, Bittencourt MS.
    Arq Bras Cardiol; 2020 Sep 01; 115(3):440-449. PubMed ID: 33027365
    [Abstract] [Full Text] [Related]

  • 45. Real-life evaluation of European and American high-risk strategies for primary prevention of cardiovascular disease in patients with first myocardial infarction.
    Mortensen MB, Falk E.
    BMJ Open; 2014 Oct 17; 4(10):e005991. PubMed ID: 25326211
    [Abstract] [Full Text] [Related]

  • 46. Collective impact of conventional cardiovascular risk factors and coronary calcium score on clinical outcomes with or without statin therapy: The St Francis Heart Study.
    Waheed S, Pollack S, Roth M, Reichek N, Guerci A, Cao JJ.
    Atherosclerosis; 2016 Dec 17; 255():193-199. PubMed ID: 27693004
    [Abstract] [Full Text] [Related]

  • 47. Applicability and potential clinical effects of 2013 cholesterol guidelines on major cardiovascular events.
    Ko MJ, Kim YJ, Park CM, Lee SM, Lee WJ, Pencina MJ, Navar-Boggan AM, Park DW.
    Am Heart J; 2015 Sep 17; 170(3):598-605.e7. PubMed ID: 26385045
    [Abstract] [Full Text] [Related]

  • 48. Recent Update to the US Cholesterol Treatment Guidelines: A Comparison With International Guidelines.
    Nayor M, Vasan RS.
    Circulation; 2016 May 03; 133(18):1795-806. PubMed ID: 27143546
    [Abstract] [Full Text] [Related]

  • 49. Assessing gaps in cholesterol treatment guidelines for primary prevention of cardiovascular disease based on available randomised clinical trial evidence: The Rotterdam Study.
    Pavlović J, Greenland P, Deckers JW, Kavousi M, Hofman A, Ikram MA, Franco OH, Leening MJ.
    Eur J Prev Cardiol; 2018 Mar 03; 25(4):420-431. PubMed ID: 29171772
    [Abstract] [Full Text] [Related]

  • 50. What's next for dyslipidemia management? The 2013 ACC/AHA Guidelines, the NLA recommendations, and beyond.
    Waite LH, Phan YL, Spinler SA.
    J Am Pharm Assoc (2003); 2016 Mar 03; 56(3):284-92. PubMed ID: 27156942
    [Abstract] [Full Text] [Related]

  • 51. ACC/AHA guidelines superior to ESC/EAS guidelines for primary prevention with statins in non-diabetic Europeans: the Copenhagen General Population Study.
    Mortensen MB, Nordestgaard BG, Afzal S, Falk E.
    Eur Heart J; 2017 Feb 21; 38(8):586-594. PubMed ID: 28363217
    [Abstract] [Full Text] [Related]

  • 52. Under-prescription of statins in patients with non-alcoholic fatty liver disease.
    Del Ben M, Baratta F, Polimeni L, Pastori D, Loffredo L, Averna M, Violi F, Angelico F.
    Nutr Metab Cardiovasc Dis; 2017 Feb 21; 27(2):161-167. PubMed ID: 27914698
    [Abstract] [Full Text] [Related]

  • 53. Evaluation of Statin Prescribing for Secondary Prevention in Primary Care Following New Guideline Recommendations.
    Zupec JF, Marrs JC, Saseen JJ.
    Ann Pharmacother; 2016 Jan 21; 50(1):17-21. PubMed ID: 26416950
    [Abstract] [Full Text] [Related]

  • 54. Statin Eligibility for Primary Prevention of Cardiovascular Disease According to 2021 European Prevention Guidelines Compared With Other International Guidelines.
    Mortensen MB, Tybjærg-Hansen A, Nordestgaard BG.
    JAMA Cardiol; 2022 Aug 01; 7(8):836-843. PubMed ID: 35793078
    [Abstract] [Full Text] [Related]

  • 55. Subclinical Atherosclerosis, Statin Eligibility, and Outcomes in African American Individuals: The Jackson Heart Study.
    Shah RV, Spahillari A, Mwasongwe S, Carr JJ, Terry JG, Mentz RJ, Addison D, Hoffmann U, Reis J, Freedman JE, Lima JAC, Correa A, Murthy VL.
    JAMA Cardiol; 2017 Jun 01; 2(6):644-652. PubMed ID: 28315622
    [Abstract] [Full Text] [Related]

  • 56. Sex disparity persists in the prevention of cardiovascular disease in women on statin therapy compared to that in men.
    Moreno-Arellano S, Delgado-de-Mendoza J, Santi-Cano MJ.
    Nutr Metab Cardiovasc Dis; 2018 Aug 01; 28(8):810-815. PubMed ID: 29754716
    [Abstract] [Full Text] [Related]

  • 57. A systematic examination of the 2013 ACC/AHA pooled cohort risk assessment tool for atherosclerotic cardiovascular disease.
    Karmali KN, Goff DC, Ning H, Lloyd-Jones DM.
    J Am Coll Cardiol; 2014 Sep 09; 64(10):959-68. PubMed ID: 25190228
    [Abstract] [Full Text] [Related]

  • 58. Implications of the 2013 ACC/AHA cholesterol guidelines for adults in contemporary cardiovascular practice: insights from the NCDR PINNACLE registry.
    Maddox TM, Borden WB, Tang F, Virani SS, Oetgen WJ, Mullen JB, Chan PS, Casale PN, Douglas PS, Masoudi FA, Farmer SA, Rumsfeld JS.
    J Am Coll Cardiol; 2014 Dec 02; 64(21):2183-92. PubMed ID: 25447259
    [Abstract] [Full Text] [Related]

  • 59. Implications of the new American College of Cardiology/American Heart Association cholesterol guidelines for primary atherosclerotic cardiovascular disease event prevention in a multi ethnic cohort: Multi-Ethnic Study of Atherosclerosis (MESA).
    Yeboah J, Sillau S, Delaney JC, Blaha MJ, Michos ED, Young R, Qureshi WT, McClelland R, Burke GL, Psaty BM, Herrington DM.
    Am Heart J; 2015 Mar 02; 169(3):387-395.e3. PubMed ID: 25728729
    [Abstract] [Full Text] [Related]

  • 60. Projected Changes in Statin and Antihypertensive Therapy Eligibility With the AHA PREVENT Cardiovascular Risk Equations.
    Diao JA, Shi I, Murthy VL, Buckley TA, Patel CJ, Pierson E, Yeh RW, Kazi DS, Wadhera RK, Manrai AK.
    JAMA; 2024 Sep 24; 332(12):989-1000. PubMed ID: 39073797
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.